"TNFSF9" Related Products

Expand
Expand

Recombinant Human TNFSF9, FLAG-tagged

Cat. No.: TNFSF9-2075H
Product Overview: Recombinant Human TNFSF9 is produced inHEK 293 Cells.The extracellular domain of human CD137L (aa 49-254) is fused at the N-terminus to a linker peptide (10 aa) and a FLAG-tag. MW=27kDa.
Description: Biologically active CD137L (4-1BBL; TNFSF 9) comprising the whole extracellular tail domain (aa 49-93), which is important for the cross-linking of the protein that is essential for its biological activity.
Source: HEK 293 Cells.
Purity: ≥95% (SDS-PAGE).
Concentration: 0.1mg/ml after reconstitution.
Formulation: Lyophilized. Contains PBS and 5% trehalose.
Endotoxin Content: <0.1EU/µg purified protein (LAL test; Bio Whittaker).
Reconstitution: Reconstitute with 100µl sterile distilled water. Further dilutions should be made with medium containing 5% fetal calf serum.
Specificity: Binds to human CD137 (4-1BB).
Storage: Stable for at least 6 months after receipt when stored at -20°C.
Handling: After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles.
Gene Name: TNFSF9 tumor necrosis factor (ligand) superfamily, member 9 [ Homo sapiens ]
Synonyms: TNFSF9; tumor necrosis factor (ligand) superfamily, member 9; CD137L; 4-1BB-L; TNFSF9; tumor necrosis factor (ligand) superfamily, member 9;receptor 4-1BB ligand; homolog of mouse 4-1BB-L; 4-1BBL; 4-1BB ligand; receptor 4-1BB ligand
Gene ID: 8744
mRNA Refseq: NM_003811
Protein Refseq: NP_003802
MIM: 606182
UniProt ID: P41273
Chromosome Location: 19p13.3
Pathway: Cytokine-cytokine receptor interaction
Function: cytokine activity; tumor necrosis factor receptor binding

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.